|
Year to Dec 2024
12 months to Dec 31, 2024
|
Year to Dec 2023
12 months to Dec 31, 2023
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Payment of office expenses made by sponsor | ||
| Courtesy discount on legal fees | ||
| Prepaid expenses | ||
| Accounts payable and accrued expenses | ||
| Change in fair value of Overallotment liability | ||
| Interest earned on marketable securities held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current asset | ||
| Short-term prepaid insurance | ||
| Accounts payable | ||
| Accrued expenses | ||
| Accrued offering cost | ||
| Income taxes payable | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash into trust Account | ||
| Cash withdrawn from Trust Account to pay franchise and income taxes | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from promissory note - related party | ||
| Proceeds from promissory note | ||
| Proceeds from loan payable | ||
| Proceeds from sale of private placements warrants | ||
| Repayment of promissory note - related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash and cash equivalents | ||
| Cash and cash equivalents – Beginning of period | ||
| Cash and cash equivalents – End of period | ||
| Non-Cash investing and financing activities: | ||
| Remeasurement of Common Stock subject to possible redemption | ||
| Deferred underwriting fee payable | ||
| Issuance of representative shares | ||
| Issuance of founder shares | ||
| Offering costs included in accrued offering costs | ||
| Offering costs paid via promissory notes |
Loading...
